Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram for obesity with binge eating disorder
2012-004951-35Phase 2Active
- Sponsor
- Azienda Ospedaliero Universitaria di Cagliari
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of disulfiram in obesity and binge eating disorder (BED), sponsored by Azienda Ospedaliero Universitaria di Cagliari. Primary endpoints: Frequency of binge eating episodes, Body weight and 3 more. Started Nov 2012; status: active.
02
Drugs
disulfiram
03
Conditions
obesitybinge eating disorder (BED)
Beyond the preview
Go deeper on 2012-004951-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004951-35.